All Stories

  1. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016

    Article • Eurosurveillance, August 2016, European Centre for Disease Control and Prevention (ECDC)

    Dr Marco Iannetta

  2. Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation

    Article • PLoS ONE, August 2016, PLOS

    Dr Marco Iannetta

  3. HIV-associated progressive multifocal leukoencephalopathy: current perspectives

    Article • Neurobehavioral HIV Medicine, August 2016, Dove Medical Press

    Dr Marco Iannetta

  4. Blood Myeloid Dendritic Cells and slanDC in Antiretroviral Therapy- Suppressed HIV-Infected Patients

    Article • Current HIV Research, June 2016, Bentham Science Publishers

    Dr Marco Iannetta

  5. Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients

    Article • PLoS ONE, February 2016, PLOS

    Dr Marco Iannetta

  6. Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing

    Article • Medicine, February 2016, Wolters Kluwer Health

    Dr Marco Iannetta

  7. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment

    Article • Journal of NeuroVirology, May 2015, Springer Science + Business Media

    Dr Marco Iannetta

  8. Role of Sonication in the Microbiological Diagnosis of Implant-Associated Infections: Beyond the Orthopedic Prosthesis

    Article • January 2015, Springer Science + Business Media

    Dr Marco Iannetta

  9. Altered antigen-presenting cells during HIV-1 infection

    Article • Current Opinion in HIV and AIDS, September 2014, Wolters Kluwer Health

    Dr Marco Iannetta

  10. Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis

    Article • Mediators of Inflammation, January 2014, Hindawi Publishing Corporation

    Dr Marco Iannetta

  11. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity

    Article • Journal of NeuroVirology, May 2013, Springer Science + Business Media

    Dr Marco Iannetta

  12. Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin

    Article • ISRN AIDS, January 2013, Hindawi Publishing Corporation

    Dr Marco Iannetta

  13. Pacemaker Lead Endocarditis Due to Multidrug-ResistantCorynebacterium striatumDetected with Sonication of the Device

    Article • Journal of Clinical Microbiology, October 2010, ASM Journals

    Dr Marco Iannetta

  14. Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline

    Article • International Journal of Infectious Diseases, June 2010, Elsevier

    Dr Marco Iannetta

  15. In Vivo Release of Alpha-Defensins in Plasma, Neutrophils and CD8 TLymphocytes of Patients with HIV Infection

    Article • Current HIV Research, November 2009, Bentham Science Publishers

    Dr Marco Iannetta

  16. In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response

    Article • PLoS ONE, April 2009, PLOS

    PhD Ilria Sauzullo, Dr Marco Iannetta